Aurobindo to market diabetes drug in S Africa
After USA, Aurobindo Pharma is all set to market its diabetes drug Metformin tablets in South Africa, as it has received marketing authorisation approval from the local Medicines Control Council (MCC).
By PTI |
MUMBAI: After USA, Aurobindo Pharma is all set to market its diabetes drug Metformin tablets in South Africa, as it has received marketing authorisation approval from the local Medicines Control Council (MCC).
The company has received another marketing authorization approval for Metformin tablets from Medicines Control Council (MCC) of South Africa, Aurobindo Pharma informed the Bombay Stock Exchange.
The council has approved Metformin tablets of multiple strengths like 500mg, 850mg and 1gm strengths and it is the eighth it added. Aurobindo is already marketing Metformin successfully in the US.
Metformin was originally made by US-based Bristol Myers Squibb and is popularly known as Glucophage and is mostly used in Type II diabetes especially in obese and insulin resistance cases.
Metformin helps to increase insulin sensitivity and decreases absorption of glucose from Gastro Intestinal tract. The drug at present commands a market of 15 million dollar in South Africa.
ADVERTISEMENT
Recently, the company received authorisation from MCC South Africa for manufacturing hypertension drug Lisinopril tablets in 5 mg, 10 mg, and 20 mg strengths. Lisinopril is the generic version of Zestril marketed by Zeneca and commands a market value of 27 million dollars.Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
